| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | developmental pigmentation | 3.35e-05 | 58 | 65 | 4 | GO:0048066 | |
| Domain | FerI | 1.30e-04 | 5 | 68 | 2 | SM01202 | |
| Domain | FerB | 1.30e-04 | 5 | 68 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 1.30e-04 | 5 | 68 | 2 | IPR012561 | |
| Domain | Ferlin_C | 1.30e-04 | 5 | 68 | 2 | PF16165 | |
| Domain | Ferlin_C | 1.30e-04 | 5 | 68 | 2 | IPR032362 | |
| Domain | FerIin_dom | 1.30e-04 | 5 | 68 | 2 | IPR012968 | |
| Domain | FerI | 1.30e-04 | 5 | 68 | 2 | PF08151 | |
| Domain | FerB | 1.30e-04 | 5 | 68 | 2 | PF08150 | |
| Domain | C2 | 1.33e-03 | 131 | 68 | 4 | PF00168 | |
| Domain | C2 | 1.57e-03 | 137 | 68 | 4 | SM00239 | |
| Domain | C2 | 1.79e-03 | 142 | 68 | 4 | PS50004 | |
| Domain | - | 2.08e-03 | 148 | 68 | 4 | 2.60.40.150 | |
| Domain | - | 2.61e-03 | 261 | 68 | 5 | 1.10.238.10 | |
| Domain | C2_dom | 3.02e-03 | 164 | 68 | 4 | IPR000008 | |
| Domain | EF-hand-dom_pair | 3.92e-03 | 287 | 68 | 5 | IPR011992 | |
| Domain | RASGEF | 4.01e-03 | 26 | 68 | 2 | PS00720 | |
| Pubmed | Thrombosis Related ABO, F5, MTHFR, and FGG Gene Polymorphisms in Morbidly Obese Patients. | 1.16e-05 | 3 | 69 | 2 | 27999448 | |
| Pubmed | Testis-enriched ferlin, FER1L5, is required for Ca2+-activated acrosome reaction and male fertility. | 1.16e-05 | 3 | 69 | 2 | 36696506 | |
| Pubmed | 1.16e-05 | 3 | 69 | 2 | 19515723 | ||
| Pubmed | Reduced thrombin generation increases host susceptibility to group A streptococcal infection. | 1.16e-05 | 3 | 69 | 2 | 19056689 | |
| Pubmed | Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma. | 1.16e-05 | 3 | 69 | 2 | 24951429 | |
| Pubmed | 2.32e-05 | 4 | 69 | 2 | 11748101 | ||
| Pubmed | 3.91e-05 | 33 | 69 | 3 | 21658281 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 10829076 | ||
| Pubmed | 5.79e-05 | 6 | 69 | 2 | 25407941 | ||
| Pubmed | Genetics of venous thrombosis: insights from a new genome wide association study. | 8.09e-05 | 7 | 69 | 2 | 21980494 | |
| Pubmed | 1.08e-04 | 8 | 69 | 2 | 23650146 | ||
| Pubmed | The Nab2 and Stat6 genes share a common transcription termination region. | 1.73e-04 | 10 | 69 | 2 | 9126479 | |
| Pubmed | Genetic variation associated with preterm birth: a HuGE review. | 2.11e-04 | 11 | 69 | 2 | 16301860 | |
| Pubmed | Gene variants associated with venous thrombosis: confirmation in the MEGA study. | 2.53e-04 | 12 | 69 | 2 | 20128871 | |
| Pubmed | 2.98e-04 | 13 | 69 | 2 | 18848323 | ||
| Pubmed | Distribution of the mammalian Stat gene family in mouse chromosomes. | 2.98e-04 | 13 | 69 | 2 | 8530075 | |
| Pubmed | 3.48e-04 | 14 | 69 | 2 | 26682986 | ||
| Pubmed | Genetic predictors of fibrin D-dimer levels in healthy adults. | 4.57e-04 | 16 | 69 | 2 | 21502573 | |
| Pubmed | 5.18e-04 | 17 | 69 | 2 | 21490707 | ||
| Pubmed | 5.81e-04 | 18 | 69 | 2 | 20550939 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 6.83e-04 | 1489 | 69 | 10 | 28611215 | |
| Pubmed | 6.98e-04 | 201 | 69 | 4 | 25192599 | ||
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 25017104 | ||
| Pubmed | 7.95e-04 | 21 | 69 | 2 | 19158679 | ||
| Pubmed | Genome-wide Identification of Foxf2 Target Genes in Palate Development. | 9.55e-04 | 23 | 69 | 2 | 32040930 | |
| Pubmed | Cis-Repression of Foxq1 Expression Affects Foxf2-Mediated Gene Expression in Palate Development. | 9.55e-04 | 23 | 69 | 2 | 33898467 | |
| Pubmed | IRF8 Regulates Transcription of Naips for NLRC4 Inflammasome Activation. | 9.55e-04 | 23 | 69 | 2 | 29576451 | |
| Pubmed | Biochemical and phosphoproteomic analysis of the helix-loop-helix protein E47. | 1.82e-03 | 121 | 69 | 3 | 22354994 | |
| Pubmed | 1.84e-03 | 650 | 69 | 6 | 38777146 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q11 | 8.66e-05 | 153 | 69 | 4 | chr2q11 | |
| GeneFamily | Ferlin family | 9.86e-05 | 6 | 47 | 2 | 828 | |
| GeneFamily | Olfactory receptors, family 6 | 3.14e-04 | 51 | 47 | 3 | 153 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.47e-06 | 163 | 69 | 5 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(MGE-derived_cortical_interneurons--Chandelier_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.49e-06 | 83 | 69 | 4 | e7f7ad1cd8b08172ef2432a80554aa8174a6c675 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(MGE-derived_cortical_interneurons--Chandelier_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 8.49e-06 | 83 | 69 | 4 | 33fa6e4a01be4d9945b273c884066d4bfdeaa62d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 183 | 69 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.59e-06 | 183 | 69 | 5 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 188 | 69 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.09e-05 | 188 | 69 | 5 | 6f8946d4710f6e32c937213f99b790b098b8819c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 188 | 69 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.30e-05 | 195 | 69 | 5 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | CV-Mild-1|CV / Virus stimulation, Condition and Cluster | 1.40e-05 | 198 | 69 | 5 | 4b078714c49e7befb7b113d72485e712236d35fa | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 1.44e-05 | 199 | 69 | 5 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | Endothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4) | 3.88e-05 | 122 | 69 | 4 | 2cb8bb63c69aed4d4504b9d97219b8707666f950 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 126 | 69 | 4 | 4eeea015efe17e0aae5bd76b71fa70b5149dfada | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.10e-05 | 54 | 69 | 3 | 7670a6eb185ae0d8c3c0cb17f8eaa9970355187b | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Sphkap-Excitatory_Neuron.Gad1Gad2.Sphkap-Cpne4_(Basomedial_amygdaloid_nucleus_(BMA))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.10e-05 | 54 | 69 | 3 | 79f804e73f859c0e8192d9e9e6ee2282f7f1691b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 149 | 69 | 4 | cc6224c6b79f43b97adc1ce48ca4906bff2ad318 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 149 | 69 | 4 | 24a7538b54b2a5291503c7493fefed4e45e8d710 | |
| ToppCell | MS-CD4-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 9.13e-05 | 152 | 69 | 4 | b1eba2d5a6da3eeb83d40a92976e3e8751ed18ee | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-05 | 155 | 69 | 4 | e7f49e2fdaf184fa6b4e685518004e7deff1316d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.84e-05 | 155 | 69 | 4 | 5a872ca70ae8c30b57f45a6772d7bf565e0c2663 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.06e-04 | 158 | 69 | 4 | 78b48b110b777bcc4c07cd23388bee911c0231d6 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-04 | 164 | 69 | 4 | f88871d3b9307112eb7ced4c629f5704326ecae8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 62 | 69 | 3 | dd2e222d454fb78fed8b37901cbf04c0080ed010 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.22e-04 | 62 | 69 | 3 | 6a3f990e8d59392ad909634a239b3ab4f13d8855 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.34e-04 | 168 | 69 | 4 | d6078e3a79d315d6090906e171a7d67a9206b2c7 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-NK_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 171 | 69 | 4 | f16cb64b8844c2668922c786888efaa9f873afcc | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 175 | 69 | 4 | e78bf0c33a741bb97e987e41ac33da9e623a08ec | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 1.57e-04 | 175 | 69 | 4 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Activated_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 1.64e-04 | 177 | 69 | 4 | 370aee11a6dc2c6f4366a13c3171f37bc5b32d65 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 182 | 69 | 4 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-04 | 182 | 69 | 4 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.86e-04 | 183 | 69 | 4 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.90e-04 | 184 | 69 | 4 | 7ecdf2645e9378cf2f5ce4557f2cf100e6f184ba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-04 | 185 | 69 | 4 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.94e-04 | 185 | 69 | 4 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined|Fibroblasts / Location, Cell class and cell subclass | 1.98e-04 | 186 | 69 | 4 | 403ac98f72a42721f84fbd7826f251a88ae534a2 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.02e-04 | 187 | 69 | 4 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.02e-04 | 187 | 69 | 4 | a6a112689d1c9049f57935ad9d2f4955538427de | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-04 | 188 | 69 | 4 | 1082861eb9e00409caa06d8b2a7b8e7f5fac94c9 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.06e-04 | 188 | 69 | 4 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 190 | 69 | 4 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.15e-04 | 190 | 69 | 4 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.19e-04 | 191 | 69 | 4 | b9b091d6b352d5128bb864ff52d2e5fb3387b766 | |
| ToppCell | Calu_3-infected-SARSCoV2|infected / Cell line, Condition and Strain | 2.19e-04 | 191 | 69 | 4 | 2da876d26f37a00dbdf1ee79d724306e8b20f304 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.19e-04 | 191 | 69 | 4 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.19e-04 | 191 | 69 | 4 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-NK|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.24e-04 | 192 | 69 | 4 | 59dd4f5ae9f1cca78adf60b71661092ef09e6641 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-04 | 193 | 69 | 4 | 315840bc48899f3a36d57b19197509de19716e3d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 193 | 69 | 4 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.28e-04 | 193 | 69 | 4 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.28e-04 | 193 | 69 | 4 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.28e-04 | 193 | 69 | 4 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-04 | 194 | 69 | 4 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.33e-04 | 194 | 69 | 4 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | ASK452-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.37e-04 | 195 | 69 | 4 | 20f492299a684ac1b7dd1bbc36a533cd6f9a1c93 | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.37e-04 | 195 | 69 | 4 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.37e-04 | 195 | 69 | 4 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.37e-04 | 195 | 69 | 4 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-04 | 195 | 69 | 4 | 3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3 | |
| ToppCell | CV-Moderate-1|Moderate / Virus stimulation, Condition and Cluster | 2.42e-04 | 196 | 69 | 4 | b50cfcd87c5b67806450cb8b3c6860ab97f6d3b1 | |
| ToppCell | Mild-CD8+_T_activated|World / Disease group and Cell class | 2.42e-04 | 196 | 69 | 4 | 79632190e44fcef9d7c11d9b9e37f2ebf0e6e255 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_3|COVID-19_Mild / Disease condition and Cell class | 2.42e-04 | 196 | 69 | 4 | f245e929a286cb097130572e1027b4f01be8b04d | |
| ToppCell | 5'-Adult-Appendix|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.42e-04 | 196 | 69 | 4 | a579211ef14f348d0c5a290553150222dfbf1515 | |
| ToppCell | CV-Moderate-1|CV / Virus stimulation, Condition and Cluster | 2.47e-04 | 197 | 69 | 4 | e3d00d850b4d191f9592ef993c0eaadfe5710b5f | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.47e-04 | 197 | 69 | 4 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | COVID-19_Severe-NK_activated|World / disease group, cell group and cell class | 2.47e-04 | 197 | 69 | 4 | a60db36d1a192998e3ded63e0c7c08d41689f95f | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.52e-04 | 198 | 69 | 4 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|World / disease group, cell group and cell class (v2) | 2.52e-04 | 198 | 69 | 4 | 7a0aac52d785037455e068e1b25de4b2bf0fff79 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.52e-04 | 198 | 69 | 4 | 0e918e9db9b884f5328d438e90efe065e27266ee | |
| ToppCell | Mild-CD8+_T_activated|Mild / Disease group and Cell class | 2.52e-04 | 198 | 69 | 4 | ceac1b51bacfd0dd7fe7c6a666f7927055e1f380 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.52e-04 | 198 | 69 | 4 | ce92d5fbc2eac27fb246b044fb1914ab92506275 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.52e-04 | 198 | 69 | 4 | fed823d6e684d113bcc9ff3cd1803bb001aa02fa | |
| ToppCell | severe_COVID-19-NK|World / disease group, cell group and cell class (v2) | 2.52e-04 | 198 | 69 | 4 | 36b1370ef68c4bbe0268933a6ef5e6022d992bdf | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.52e-04 | 198 | 69 | 4 | 1ef3a6bd681c223eed58300348adfef89df5563c | |
| ToppCell | BAL-Severe|BAL / Compartment, Disease Groups and Clusters | 2.52e-04 | 198 | 69 | 4 | f63cfcc57f46094ea0673bbc70ea443ebaca6176 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-04 | 199 | 69 | 4 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | VE-CD4-antiviral_CD4|VE / Condition, Cell_class and T cell subcluster | 2.56e-04 | 199 | 69 | 4 | 056a0538ca5e825ae6195b4c76c208708a014533 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 2.56e-04 | 199 | 69 | 4 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-CD14_monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-04 | 199 | 69 | 4 | 50a30d5ee99e51743a0dd60144fc341ff68da9af | |
| ToppCell | COVID-19-lung|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.56e-04 | 199 | 69 | 4 | 155b03b859157013e9142e9248551369127d9204 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.56e-04 | 199 | 69 | 4 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-04 | 200 | 69 | 4 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-04 | 200 | 69 | 4 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-NK_activated|COVID-19_Severe / Disease, condition lineage and cell class | 2.61e-04 | 200 | 69 | 4 | 6a77f9643646bafc1157bf1fc1e4c614860ee642 | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / Disease condition and Cell class | 2.61e-04 | 200 | 69 | 4 | f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.61e-04 | 200 | 69 | 4 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| Disease | eosinophilic esophagitis (is_implicated_in) | 5.21e-05 | 5 | 68 | 2 | DOID:13922 (is_implicated_in) | |
| Disease | factor VIII measurement, venous thromboembolism | 6.66e-05 | 34 | 68 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 1.09e-04 | 7 | 68 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 1.26e-04 | 42 | 68 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | pulse pressure measurement | EVA1C FBXO38 LCORL COL21A1 OR10AD1 ETFDH SCN10A SMOC2 FER1L5 PLCE1 SOS2 | 3.19e-04 | 1392 | 68 | 11 | EFO_0005763 |
| Disease | Ischemic stroke, venous thromboembolism, stroke, Abnormal thrombosis, deep vein thrombosis, pulmonary embolism | 6.96e-04 | 17 | 68 | 2 | EFO_0000712, EFO_0003827, EFO_0003907, EFO_0004286, HP_0001977, HP_0002140 | |
| Disease | prothrombin time measurement | 1.07e-03 | 21 | 68 | 2 | EFO_0008390 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 1.07e-03 | 21 | 68 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 1.28e-03 | 23 | 68 | 2 | EFO_0004286, EFO_0004791 | |
| Disease | partial thromboplastin time | 1.40e-03 | 24 | 68 | 2 | EFO_0004310 | |
| Disease | D dimer measurement | 2.18e-03 | 30 | 68 | 2 | EFO_0004507 | |
| Disease | factor XI measurement, venous thromboembolism | 2.18e-03 | 30 | 68 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | venous thromboembolism, factor VII measurement | 3.49e-03 | 38 | 68 | 2 | EFO_0004286, EFO_0004619 | |
| Disease | type 1 diabetes mellitus (implicated_via_orthology) | 3.67e-03 | 39 | 68 | 2 | DOID:9744 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVKYFPFDQQNCTLK | 156 | P30926 | |
| QDQIFPNLDKFLCLK | 1091 | Q13075 | |
| IKLLDCDQELYKNFP | 496 | P35626 | |
| KCQFAQKIREFKLLP | 161 | A6NMK7 | |
| PQFYFAKAKRLDLCQ | 81 | A8MX76 | |
| KNIYRPDKFLQCVKN | 276 | P28907 | |
| QEFQRLLKELPECNY | 301 | Q15311 | |
| EDLLKNPFYLALQKC | 6 | Q96NW4 | |
| CNPIIYSFRNKEIKE | 286 | Q8NGE0 | |
| DAICRLQKKNLFPYN | 721 | Q8NG48 | |
| QPNCYVLKNKDLEQA | 601 | Q6DN12 | |
| YLKRNQFEVFPQELC | 171 | A6NIV6 | |
| QKIVQKNRSKYDDPC | 541 | A6NM62 | |
| LNALFRKKDLPQNCD | 136 | Q8N3X6 | |
| QQYSPEILACQFLKK | 766 | Q9UPZ3 | |
| YKCLRNFLQEKDFCP | 71 | Q8N448 | |
| CFKDNLNKPYLFSVL | 91 | Q9GZN4 | |
| SQKDKNFNLPRLCIR | 211 | Q9H0R5 | |
| EYFPECLNLIKDKNL | 956 | O95163 | |
| NHKTNDRCQLKFLPY | 706 | Q969R2 | |
| LANNPCEREKRNIYK | 511 | Q9NYA4 | |
| NLLKVYFPDVQFNRC | 461 | Q3B8N5 | |
| NAPIVNRFDYAQCKK | 966 | Q6PIJ6 | |
| NPAIYCLRNKEVKEA | 286 | Q8NGX9 | |
| KPLKANQQFLVYCEI | 196 | P02679 | |
| YLLVSFKCQPNELKN | 151 | P58658 | |
| LYKKFDLRANCEPQT | 256 | Q16134 | |
| YNCELPQNCKEVKRL | 1731 | Q9P2N4 | |
| QCYKRALDAQIKNKP | 481 | Q6ZN84 | |
| ALAEFLCLNYKKNPA | 1006 | O75976 | |
| FDVQKLRIYCDPEQN | 401 | Q96P44 | |
| DPNNIKTNAKLYCNR | 286 | Q99615 | |
| CRFKDAFQQYPDLLK | 221 | Q86TM3 | |
| NERLKKYPNDCQDGL | 596 | Q6SJ93 | |
| KELQSLYRGFKNECP | 91 | Q9Y2W7 | |
| FNCLYKNPEATFKLI | 16 | Q9NV23 | |
| CYNAQAIFKQKLPVA | 121 | P14778 | |
| NPLIYCLRNKEFKDA | 286 | Q6IFH4 | |
| TINYLKQFLCKLREP | 1081 | Q2WGJ9 | |
| EKYLRDVNCPFKIQD | 61 | Q9Y224 | |
| YLFNKSLEIEPRNCK | 1006 | Q07890 | |
| LKDQQDVFCFRYKIQ | 166 | P52630 | |
| RNEDYKEITQKLCFP | 696 | O15056 | |
| QAYIDIKNCPKKTRN | 321 | P12259 | |
| CQTFKLYQEQPKLDS | 1431 | A0AVI2 | |
| CNDKLQFEYNEEIPK | 1611 | Q9P212 | |
| YQKFLEGLQKCQRDL | 571 | Q9H9A7 | |
| LFCRQYDIIKDNEPN | 171 | Q8NAU1 | |
| PYCVKFNPDEDKQNL | 376 | O60508 | |
| LAKFRQCLQENPKFL | 471 | Q5JRX3 | |
| YAQQVLQKECRPKFA | 111 | Q9UNP4 | |
| NPLIYCLRNKEFKNA | 286 | Q8NGW1 | |
| HCKFNVPLARLNQKY | 41 | Q8TDG2 | |
| NILPKCQDQDFLPKY | 621 | Q0P6D6 | |
| LKNFKRCLQLEPYNE | 371 | Q8NBP0 | |
| VVDCKKEAFRLQPYN | 246 | Q3ZCQ8 | |
| ERPYKCNECIKTFNQ | 151 | Q5EBM4 | |
| PKRIYFNKQENCILL | 2366 | Q96RL7 | |
| NIQILKQPFDYNKCG | 201 | Q9HCZ1 | |
| KECQAPKRELNQVLY | 36 | Q9H171 | |
| DLKACNQLPKFYGEL | 56 | Q9Y5Y9 | |
| FQRAKCKDPQLEIAY | 66 | Q9H3U7 | |
| AQVRKAVQYEEKNPC | 261 | O75558 | |
| FRRCPFLEQEQAKKY | 156 | Q6ZV50 | |
| NCELVKKFLDPNNYS | 111 | Q7Z7A4 | |
| KQKCLYNLPFKRNLE | 1921 | Q8WWQ8 | |
| VQYKKFQAREKPNVC | 251 | Q2M218 | |
| NSECLKEQQKRYFPV | 366 | Q08AF3 | |
| VKNDTERKFCYQQLP | 936 | Q9P2D8 |